This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CBO Report Lowballs Likely Obamacare Impact on Employment, Economy

NEW YORK (TheStreet) -- In a new report, the Congressional Budget Office once again lowballed the impact of the Affordable Care Act on labor force participation and the economy, in my view. I think that GDP, growth and employment for most workers will be harmed.

The CBO estimates that employment will be cut by 1.5% to 2%, thanks to workers choosing to cut hours or not work at all to obtain Obamacare subsidies for private insurance or maintain eligibility for Medicaid.

According to the report, lower employment only translates into a 1% reduction in workers' compensation, owing to the concentration of those in low-wage categories. However, I think the report fails to adequately calibrate the impact of higher Medicare taxes and the surcharge on interest, dividends and capital gains on the participation of older workers -- especially high-productivity and entrepreneurial workers and business owners over 50 -- who were not inclined to cut hours or retire altogether before now.

In addition, I think the CBO fails to consider the consequences of distorted career paths on labor productivity, negative effects on R&D spending and lower investment overall in the U.S. Those activities will be lost to China, Japan and Germany and other competitors in Asia and Europe owing to their lower health care costs.

Major industrialized competitors in Europe and Asia spend 9% to 12% of GDP on their universal health care, and often attain higher health care outcomes, while the United States spends 18%. And Medicare and Medicaid's own actuaries expect the latter figure to rise under Obamacare, thanks to the inadequacies of cost controls.

Must Read: Obama: U.S. Can Help More People Join Middle Class

Costs -- direct taxes and business outlays for health insurance or penalties for failing to provide health care, as mandated by the Affordable Care Act -- weigh heavily on cost competitiveness and decisions to locate manufacturing and service activities in the U.S., in my view. Especially at risk are jobs critical to R&D effort and innovation.

The Obama Administration argues that subsidies for health care and Medicaid give Americans more personal choices, and decisions not to work might improve the performance of the economy. If I take this to its logical conclusion, the Administration should provide direct cash payments to workers to abstain from seeking employment.

The impact on the economy beginning this year and escalating through the decade is likely in the range of $240 to $320 billion. I think this will damage the viability of the Social Security trust fund and shake state and local government finances. More cities, like Detroit, will likely face bankruptcies. States like Illinois may face a lower credit rating and be forced to reduce funding for education, public safety and the like.

By failing to address the handicap imposed on American businesses by higher health care costs, the Affordable Care Act, like other efforts to equalize income, will in my opinion slow growth to a pace more akin to lethargic European economies than emerging competitors in Asia.

At the time of publication, the author held no positions in any of the stocks mentioned.

This article represents the opinion of a contributor and not necessarily that of TheStreet or its editorial staff.

Peter Morici is an economist and professor at the Smith School of Business, University of Maryland and a widely published columnist. He tweets @pmorici1

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $118.29 -0.01%
FB $105.98 1.70%
GOOG $762.27 2.60%
TSLA $234.22 1.70%
YHOO $33.72 -0.27%


Chart of I:DJI
DOW 17,837.38 +117.46 0.66%
S&P 500 2,091.65 +11.24 0.54%
NASDAQ 5,131.1370 +22.4710 0.44%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs